1 Min Read
April 10 (Reuters) - GB Sciences Inc:
* EXPECTS TO COMMENCE ITS FIRST-IN-HUMAN TRIAL IN EARLY 2019
* COMPANY WILL BEGIN ITS TOXICOLOGY STUDIES IN SUMMER OF 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.